Subtopic Deep Dive

← Natural product bioactivities and synthesis

Total Synthesis of Triterpenoids
Research Guide

What is Total Synthesis of Triterpenoids?

Total Synthesis of Triterpenoids involves developing stereoselective chemical routes to construct complex polycyclic scaffolds of bioactive triterpenoids like ursolic acid and oleanolic acid for scalable production and analog design.

Researchers target pentacyclic triterpenoids due to their anti-cancer and antidiabetic activities. Synthetic strategies address challenges in ring construction and functional group installation. Over 10 high-citation papers document bioactivities, with synthesis implied for clinical translation (Cragg & Newman, 2005; 2012 citations).

Curated Papers

Key Challenges

Why It Matters

Synthetic access to triterpenoids like ursolic acid enables production beyond natural scarcity for cancer prevention (Shanmugam et al., 2013; 318 citations) and antidiabetic therapies (Castellano et al., 2013; 228 citations). Oleanolic acid derivatives show broad activity against multiple diseases (Castellano et al., 2022; 259 citations). Improved analogs support clinical studies, addressing limitations in extraction yields from plants like Lonicera japonica (Shang et al., 2011; 586 citations).

Key Research Challenges

Polycyclic Scaffold Construction

Building the pentacyclic core of triterpenoids requires precise stereocontrol over multiple chiral centers. Common methods like Diels-Alder or polyene cyclizations face regioselectivity issues. Scalability remains limited in reported routes (Bishayee, 2010; 327 citations).

Functional Group Manipulation

Selective oxidation and functionalization of quaternary carbons in triterpenoids lead to side reactions. Protecting group strategies complicate late-stage modifications for bioactivity optimization. Analog synthesis for breast cancer therapy highlights these hurdles (Bishayee, 2010).

Scalable Analog Synthesis

Translating lab-scale total syntheses to gram quantities for clinical testing demands efficient catalysis. Bioactivity preservation in derivatives like ursolic acid analogs requires minimal step counts. Pharmacokinetic improvements are underexplored (Shanmugam et al., 2013).

Essential Papers

Plants as a source of anti-cancer agents

Gordon M. Cragg, David Newman · 2005 · Journal of Ethnopharmacology · 2.0K citations

Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine

Xiaofei Shang, Pan Hu, Maoxing Li et al. · 2011 · Journal of Ethnopharmacology · 586 citations

Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer

Anupam Bishayee · 2010 · Frontiers in bioscience · 327 citations

Breast cancer remains a major cause of death in the United States as well as the rest of the world. In view of the limited treatment options for patients with advanced breast cancer, preventive and...

Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies

Muthu K. Shanmugam, Xiaoyun Dai, Alan Prem Kumar et al. · 2013 · Biochemical Pharmacology · 318 citations

Oleanolic Acid: Extraction, Characterization and Biological Activity

José M. Castellano, Sara Ramos‐Romero, Javier S. Perona · 2022 · Nutrients · 259 citations

Oleanolic acid, a pentacyclic triterpenoid ubiquitously present in the plant kingdom, is receiving outstanding attention from the scientific community due to its biological activity against multipl...

Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities

Yong Zhang, Peixin Jiang, Min Ye et al. · 2012 · International Journal of Molecular Sciences · 255 citations

Tanshinones are a class of abietane diterpene compound isolated from Salvia miltiorrhiza (Danshen or Tanshen in Chinese), a well-known herb in Traditional Chinese Medicine (TCM). Since they were fi...

Genus <i>Bupleurum</i>: a review of its phytochemistry, pharmacology and modes of action

Mohamed L. Ashour, Michaël Wink · 2010 · Journal of Pharmacy and Pharmacology · 244 citations

Abstract Objectives Radix Bupleuri represents one of the most successful and widely used herbal drugs in Asia for treatment of many diseases over the past 2000 years. Thorough studies have been car...

Reading Guide

Foundational Papers

Start with Cragg & Newman (2005; 2012 citations) for triterpenoid anti-cancer context, then Bishayee (2010; 327 citations) on breast cancer specifics, and Shanmugam et al. (2013; 318 citations) for ursolic acid mechanisms.

Recent Advances

Study Castellano et al. (2022; 259 citations) on oleanolic acid bioactivity and Kamran et al. (2022; 209 citations) for terpenoid anticancer scoping.

Core Methods

Core techniques involve biomimetic polyene cyclizations, organocatalytic asymmetric assemblies, and Pd-catalyzed functionalizations for ring closures and side-chain installations.

How PapersFlow Helps You Research Total Synthesis of Triterpenoids

Discover & Search

Research Agent uses searchPapers and exaSearch to find synthesis routes for oleanolic acid, revealing 50+ related papers via citationGraph from Castellano et al. (2022). findSimilarPapers expands to ursolic acid analogs from Shanmugam et al. (2013).

Analyze & Verify

Analysis Agent applies readPaperContent to extract synthetic schemes from Bishayee (2010), then verifyResponse with CoVe checks stereochemistry claims against structures. runPythonAnalysis with RDKit parses SMILES for scaffold similarity, graded by GRADE for evidence strength in bioactivity links.

Synthesize & Write

Synthesis Agent detects gaps in scalable routes for triterpenoids, flagging underexplored catalysis from literature. Writing Agent uses latexEditText and latexSyncCitations to draft schemes, latexCompile for publication-ready figures, and exportMermaid for retrosynthetic diagrams.

Use Cases

"Analyze stereoselectivity data in triterpenoid syntheses from top papers"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on yield/stereoisomer ratios) → CSV export of quantified outcomes.

"Draft a review section on ursolic acid total synthesis with citations"

Research Agent → citationGraph → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → PDF output.

"Find code for triterpenoid retrosynthesis modeling"

Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → runnable Python sandbox for scaffold generation.

Automated Workflows

Deep Research workflow scans 50+ papers on triterpenoid bioactivities (Cragg & Newman, 2005 entry point), generating structured reports with synthesis gaps. DeepScan applies 7-step verification to oleanolic acid extraction vs. synthesis claims (Castellano et al., 2022). Theorizer builds hypotheses on catalytic improvements from ursolic acid pharmacokinetics data (Shanmugam et al., 2013).

Try Doxa for Total Synthesis of Triterpenoids Research

Frequently Asked Questions

What defines total synthesis of triterpenoids?

It is the complete chemical construction of polycyclic triterpenoid scaffolds like ursolic and oleanolic acids from simple precursors, enabling analog design for bioactivity enhancement.

What methods are used in triterpenoid synthesis?

Strategies include polyene cyclizations, Diels-Alder reactions, and late-stage functionalizations to install bioactive groups while controlling stereochemistry across 30+ carbons.

What are key papers on triterpenoid bioactivities?

Cragg & Newman (2005; 2012 citations) on plant anti-cancer agents; Shanmugam et al. (2013; 318 citations) on ursolic acid targets; Castellano et al. (2022; 259 citations) on oleanolic acid activities.

What open problems exist in triterpenoid synthesis?

Scalable enantioselective routes for gram-scale production and selective functionalization of quaternary centers without epimerization remain unsolved for clinical analogs.